Capricor Therapeutics
CAPR
CAPR
17 hedge funds and large institutions have $279K invested in Capricor Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
89% less capital invested
Capital invested by funds: $2.44M → $279K (-$2.17M)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.3K | |
| 2 | +$52K | |
| 3 | +$15K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.67K |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$56K | |
| 3 | -$2K | |
| 4 |
Morgan Stanley
New York
|
-$1.96K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$668 |